Odomi M - Search Results

1

Chiral inversion of drug: role of intestinal bacteria in the stereoselective sulphoxide reduction of flosequinan.

Kashiyama E, Yokoi T, Todaka T, Odomi M, Kamataki T. Kashiyama E, et al. Among authors: odomi m. Biochem Pharmacol. 1994 Jul 19;48(2):237-43. doi: 10.1016/0006-2952(94)90093-0. Biochem Pharmacol. 1994. PMID: 8053920

2

Stereospecific and simultaneous high-performance liquid chromatographic assay of flosequinan and its metabolites in human plasma.

Kashiyama E, Odomi M, Shimizu T. Kashiyama E, et al. Among authors: odomi m. J Chromatogr. 1994 Feb 11;652(2):179-85. doi: 10.1016/0378-4347(93)e0383-2. J Chromatogr. 1994. PMID: 8006102

3

Stereoselective pharmacokinetics and interconversions of flosequinan enantiomers containing chiral sulphoxide in rat.

Kashiyama E, Todaka T, Odomi M, Tanokura Y, Johnson DB, Yokoi T, Kamataki T, Shimizu T. Kashiyama E, et al. Among authors: odomi m. Xenobiotica. 1994 Apr;24(4):369-77. doi: 10.3109/00498259409045900. Xenobiotica. 1994. PMID: 8059540

4

Stereoselective S-oxidation of flosequinan sulfide by rat hepatic flavin-containing monooxygenase 1A1 expressed in yeast.

Kashiyama E, Yokoi T, Itoh K, Itoh S, Odomi M, Kamataki T. Kashiyama E, et al. Among authors: odomi m. Biochem Pharmacol. 1994 Apr 20;47(8):1357-63. doi: 10.1016/0006-2952(94)90334-4. Biochem Pharmacol. 1994. PMID: 8185644

5

Cytochrome P450 responsible for the stereoselective S-oxidation of flosequinan in hepatic microsomes from rats and humans.

Kashiyama E, Yokoi T, Odomi M, Funae Y, Inoue K, Kamataki T. Kashiyama E, et al. Among authors: odomi m. Drug Metab Dispos. 1997 Jun;25(6):716-24. Drug Metab Dispos. 1997. PMID: 9193873

6

Stereoselective S-oxidation and reduction of flosequinan in rat.

Kashiyama E, Yokoi T, Odomi M, Kamataki T. Kashiyama E, et al. Among authors: odomi m. Xenobiotica. 1999 Aug;29(8):815-26. doi: 10.1080/004982599238263. Xenobiotica. 1999. PMID: 10553722

7

Involvement of human cytochrome P450 3A4 in reduced haloperidol oxidation.

Kudo S, Odomi M. Kudo S, et al. Among authors: odomi m. Eur J Clin Pharmacol. 1998 May;54(3):253-9. doi: 10.1007/s002280050455. Eur J Clin Pharmacol. 1998. PMID: 9681669

8

Leukopenia-inducing effect of a combination of a new 5-fluorouracil (5-FU)-derived drug, BOF-A2 (emitefur), with other 5-FU-derived drugs or BV-araU (sorivudine) in rats.

Miyauchi S, Imaoka T, Okada T, Motoyama M, Kawaguchi T, Akiyama H, Odomi M. Miyauchi S, et al. Among authors: odomi m. Jpn J Pharmacol. 1996 Feb;70(2):139-48. doi: 10.1254/jjp.70.139. Jpn J Pharmacol. 1996. PMID: 8866751 Free article.

9

Stereoselective high-performance liquid chromatographic assay for the determination of OPC-18790 enantiomers in human plasma and urine.

Kitani M, Miyamoto G, Odomi M. Kitani M, et al. Among authors: odomi m. J Chromatogr. 1993 Oct 22;620(1):97-104. doi: 10.1016/0378-4347(93)80056-a. J Chromatogr. 1993. PMID: 8106598

10

Metabolism of carteolol by cDNA-expressed human cytochrome P450.

Kudo S, Uchida M, Odomi M. Kudo S, et al. Among authors: odomi m. Eur J Clin Pharmacol. 1997;52(6):479-85. doi: 10.1007/s002280050322. Eur J Clin Pharmacol. 1997. PMID: 9342584

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

43 results

Search Page

Filters